BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34237585)

  • 1. Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.
    Merolla F; Ilardi G; Di Spigna G; Russo D; Martino F; Varricchio S; Dell'Aversana GO; Mascolo M; Covelli B; Caltabiano R; Broggi G; Audino G; Celetti A; Postiglione L; Staibano S
    Oral Oncol; 2021 Sep; 120():105367. PubMed ID: 34237585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC.
    Morra F; Merolla F; Picardi I; Russo D; Ilardi G; Varricchio S; Liotti F; Pacelli R; Palazzo L; Mascolo M; Celetti A; Staibano S
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31627329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of chromatin assembly factor-1/p60 predicts biological behaviour of laryngeal carcinomas.
    Mesolella M; Iorio B; Landi M; Cimmino M; Ilardi G; Iengo M; Mascolo M
    Acta Otorhinolaryngol Ital; 2017 Feb; 37(1):17-24. PubMed ID: 28374866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker.
    Mascolo M; Ilardi G; Merolla F; Russo D; Vecchione ML; De Rosa G; Staibano S
    Int J Mol Sci; 2012; 13(9):11044-11062. PubMed ID: 23109837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
    Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
    BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chromatin assembly factor-1/p60 and poly [ADP-ribose] polymerase 1 in mycosis fungoides.
    Mascolo M; Travaglino A; Varricchio S; Russo D; Sabattini E; Agostinelli C; Bertuzzi C; Baldo A; Pileri A; Picardi M; Pane F; Staibano S
    Virchows Arch; 2021 May; 478(5):961-968. PubMed ID: 33098490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.
    Staibano S; Mascolo M; Mancini FP; Kisslinger A; Salvatore G; Di Benedetto M; Chieffi P; Altieri V; Prezioso D; Ilardi G; De Rosa G; Tramontano D
    Histopathology; 2009 Apr; 54(5):580-9. PubMed ID: 19309489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvikova M; Topolcan O; Celakovsky P; Kucera R; Windrichova J; Ludvik J; Skalova K; Kulda V; Pesta M; Plzak J
    Anticancer Res; 2017 Jun; 37(6):3281-3286. PubMed ID: 28551677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer.
    Mascolo M; Ilardi G; Romano MF; Celetti A; Siano M; Romano S; Luise C; Merolla F; Rocco A; Vecchione ML; De Rosa G; Staibano S
    Histopathology; 2012 Dec; 61(6):1089-105. PubMed ID: 22882088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
    Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
    Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
    Yamashita T; Shimada H; Tanaka S; Araki K; Tomifuji M; Mizokami D; Tanaka N; Kamide D; Miyagawa Y; Suzuki H; Tanaka Y; Shiotani A
    Cancer Med; 2016 Mar; 5(3):415-25. PubMed ID: 26798989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Hu Y; Guo G; Li J; Chen J; Tan P
    Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV.
    Paver EC; Currie AM; Gupta R; Dahlstrom JE
    Pathology; 2020 Feb; 52(2):179-191. PubMed ID: 31889547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvik J; Kucera R; Topolcan O; Celakovsky P; Pesta M; Kholova I; Plzak J; Ludvikova M
    Anticancer Res; 2019 Sep; 39(9):5171-5177. PubMed ID: 31519630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.
    Mascolo M; Vecchione ML; Ilardi G; Scalvenzi M; Molea G; Di Benedetto M; Nugnes L; Siano M; De Rosa G; Staibano S
    BMC Cancer; 2010 Feb; 10():63. PubMed ID: 20178651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.